BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35571667)

  • 1. Construction and validation of four-metabolism related-long non-coding RNAs as potential signature in prognosis of colon cancer.
    Chen G; Dong Y; Shi W; Li L; Zhu W; Xie L; Song X
    Transl Cancer Res; 2022 Apr; 11(4):725-735. PubMed ID: 35571667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
    Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F
    J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy-related long non-coding RNA signature for potential prognostic biomarkers of patients with cervical cancer: a study based on public databases.
    Feng Q; Wang J; Cui N; Liu X; Wang H
    Ann Transl Med; 2021 Nov; 9(22):1668. PubMed ID: 34988177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
    Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
    Front Oncol; 2021; 11():663263. PubMed ID: 34123820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer.
    Lin Y; Pan X; Chen Z; Lin S; Chen S
    Front Genet; 2020; 11():318. PubMed ID: 32425969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
    Fan Q; Liu B
    Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of two-lncRNA signature as a potential prognostic biomarker in cervical cancer: a study based on public database.
    Wu W; Sui J; Liu T; Yang S; Xu S; Zhang M; Huang S; Yin L; Pu Y; Liang G
    PeerJ; 2019; 7():e6761. PubMed ID: 31065456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.
    Zhang R; Zhu Q; Yin D; Yang Z; Guo J; Zhang J; Zhou Y; Yu JJ
    Front Oncol; 2020; 10():597569. PubMed ID: 33614483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs.
    Hu J; Lai C; Shen Z; Yu H; Lin J; Xie W; Su H; Kong J; Han J
    Front Oncol; 2022; 12():833763. PubMed ID: 35280814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a five-lncRNA signature with prognostic value in colon cancer.
    Lv J; Guo Y; Yan L; Lu Y; Liu D; Niu J
    J Cell Biochem; 2020 Aug; 121(8-9):3780-3793. PubMed ID: 31680309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic model associated with the overall survival in patients with breast cancer based on lipid metabolism-related long noncoding RNAs.
    Shi GJ; Zhou Q; Zhu Q; Wang L; Jiang GQ
    J Clin Lab Anal; 2022 Jun; 36(6):e24384. PubMed ID: 35441740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients.
    Chen D; Wang M; Xu Y; Jiang X; Xiong L; Zhang L; Yu H; Xiong Z
    Int J Gen Med; 2021; 14():6935-6950. PubMed ID: 34703297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNAs KB-1836B5, LINC00566 and FAM27L are associated with the survival time of patients with ovarian cancer.
    Li H; Gong M; Zhao M; Wang X; Cheng W; Xia Y
    Oncol Lett; 2018 Sep; 16(3):3735-3745. PubMed ID: 30127984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
    Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
    Front Oncol; 2021; 11():640150. PubMed ID: 33869028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.